High Tolerability: In human trials involving over 900 subjects, no anti-peptide antibodies or significant adverse events were reported
doi: 10.1093/ajcn/55.1.258s
In most cases, these symptoms are mild to moderate and improve over time, but they can be severe enough for some patients to discontinue treatment (semaglutide STEP 1 trial results)
NICE Guideline CG189 (Obesity: identification, assessment and management) emphasises the importance of structured postoperative follow-up and ongoing medical management after bariatric surgery, including regular review of medications in the context of the patient's evolving clinical needs
The appeal window varies by payer
It also helps to reduce the risk of developing heart attack, dementia, and stroke, since it decreases homocysteine levels